MG
ORGO icon

Mather Group’s Organogenesis Holdings ORGO Stock Holding History

Mather Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35,851
Closed -$96.4K – 518
2022
Q4 		$96.4K Hold
35,851
– – ﹤0.01% 473
2022
Q3 		$116K Hold
35,851
– – ﹤0.01% 462
2022
Q2 		$175K Hold
35,851
– – ﹤0.01% 368
2022
Q1 		$273K Hold
35,851
– – 0.01% 362
2021
Q4 		$331K Hold
35,851
– – 0.01% 284
2021
Q3 		$511K Buy
+35,851
New +$557K 0.01% 167

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Mather Group's ORGO Position: Q1 2023 in Review

Mather Group sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 35,851 shares — an estimated $96.4K sold.

Mather Group first reported a position in ORGO in Q3 2021 and held it in 6 quarters. The position peaked at $511K in Q3 2021. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • Mather Group reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • Mather Group sold 35,851 Organogenesis Holdings shares in Q1 2023, an estimated $96.4K.
  • Mather Group first reported a position in Organogenesis Holdings in Q3 2021 and held it in 6 quarters.
  • Mather Group's Organogenesis Holdings position peaked at $511K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Mather Group's 13F filing for Q1 2023, filed 9 May 2023.